ArticleMedicine2026
Postoperative day 3 geriatric nutritional risk index as an early warning marker for anastomotic leakage after colorectal cancer surgery: A retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anastomotic leakage (AL) is a serious complication after colorectal cancer (CRC) surgery, and early postoperative risk stratification remains clinically challenging. The Geriatric Nutritional Risk Index (GNRI) integrates serum albumin and body weight information, but its role as a postoperative marker and its incremental value beyond albumin alone remain uncertain. This single-center retrospective cohort study included 302 patients who underwent laparoscopic radical colorectal cancer surgery at Yanbian University Hospital between January 2022 and October 2024. Postoperative day 3 (POD3) GNRI and POD3 albumin were evaluated using receiver operating characteristic analysis, paired DeLong testing, correlation and variance inflation factor assessment, exploratory multivariable logistic models, model comparison, 1000-resample bootstrap internal validation, and colon versus rectum subgroup and interaction analyses. AL occurred in 16/302 patients (5.30%). POD3 albumin had a numerically higher area under the receiver operating characteristic curve (AUC) than POD3 GNRI (AUC: 0.744, 95% confidence interval [CI]: 0.617-0.870 vs AUC: 0.691, 95% CI: 0.597-0.785; DeLong P = .331). POD3 GNRI and POD3 albumin were correlated (Pearson R = 0.774; Spearman ρ = 0.761). The apparent AUCs were 0.766 for the clinical model, 0.793 for clinical plus POD3 albumin, and 0.801 for clinical plus POD3 GNRI; corresponding optimism-corrected AUCs were 0.680, 0.706, and 0.724. Bootstrap warnings about fitted probabilities approaching 0 or 1 indicated model instability. Low POD3 GNRI was associated with increased AL risk and may help identify patients for postoperative risk enrichment and heightened surveillance. However, POD3 GNRI should not be interpreted as having established added value beyond albumin alone, and its incremental value remains uncertain. These exploratory findings require external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.